Placebo A
Sponsors
Novo Nordisk A/S, University of Utah, John D. Dingell VA Medical Center, University of Waterloo, Santa Barbara Cottage Hospital
Conditions
Adenomatous Polyposis ColiAlcohol Withdrawal SyndromeChronic Kidney DiseaseCrohn's DiseaseDepressionDigestiveGastrointestinal HealthHealthy
Phase 1
To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants
CompletedNCT04389775
Start: 2020-03-29End: 2021-09-29Updated: 2021-10-28
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.
CompletedNCT07121153
Start: 2025-08-11End: 2025-12-20Updated: 2026-02-17
Phase 2
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
CompletedNCT01187901
Start: 2010-04-30End: 2014-07-31Updated: 2016-06-17
Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease
NCT04713631
Start: 2021-01-21End: 2024-01-31Target: 40Updated: 2023-05-23
Safety and efficacy of once-weekly subcutaneous and once-daily oral NNC0487-0111 in participants with type 2 diabetes – a dose finding study
CompletedCTIS2023-509412-28-00
Start: 2024-07-26End: 2025-10-08Target: 339Updated: 2025-11-24
Efficacy, safety, and pharmacokinetics of NNC0519-0130 once weekly s.c. versus semaglutide 1.0 mg and placebo in people with chronic kidney disease, with or without type 2 diabetes, and with overweight or obesity: a proof-of-concept and dose-finding study
RecruitingCTIS2024-510846-15-00
Start: 2025-04-14Target: 120Updated: 2025-10-30
Phase 4
Unknown Phase
Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.
WithdrawnNCT02223299
Start: 2015-11-30End: 2015-11-30Updated: 2020-02-21
Glutamate Supplementation in Young Men
CompletedNCT03425578
Start: 2018-03-19End: 2018-10-02Updated: 2019-06-12
Efficacy of Two Enzyme Cocktails in Healthy Adults
Not yet recruitingNCT06710392
Start: 2024-12-15End: 2025-11-30Target: 100Updated: 2024-11-29